Greece Archives - MEDIC NEST

Open Invitation: to participate at the 3rd Hellenic BioCluster Forum. An excellent opportunity for the life sciences sector and the 3rd ClusterXchange held under the Medic Nest health-tech cluster alliance

Greece MedicNestOpen Invitation: to participate at the 3rd Hellenic BioCluster Forum. An excellent opportunity for the life sciences sector and the 3rd ClusterXchange held under the Medic Nest health-tech cluster alliance

April 12, 2023by Dana GLiga

The Hellenic BioCluster, member of Medic Nest consortium, is organising its 3rd Forum on the subject of “Supporting disruptive innovation to maximize the economic and social impact of the bio-industry sector”, scheduled to be held between 15 – 17 June 2023 at Megaron Athens International Conference Centre, Athens, Greece. We are inviting you to the...

GreeceCenter of Excellence in Biobanking and Biomedical Research at University of Cyprus

January 27, 2023by pcdata

Type: Biobank Project page: Access page Country: Greece Synopsis: We, the people at Center of Excellence (CoE) biobank.cy, aspire to create an upgraded research environment with the necessary tools to develop innovative front-line research in the field of genetic diseases and molecular medicine. With the combination of research instruments that include molecular genetics and biostatistics,...

Belgium France Germany Greece Italy Spain Sweden Switzerland USAImmune profiling to guide host-directed interventions to cure HBV infections

July 19, 2022by pcdata

Dates: 01/01/2020 31/12/2024 Topic: Biomarkers identification Project type: Preclinic Clinic Immunotherapy Project target: Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.3. – Treating and managing disease Other Participating agents: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE Keywords: hepatitis B; vaccine; CHB; biomarker; clinical trial; public health;...

France Greece Ireland Italy Netherlands Norway Spain Sweden Switzerland UK USANEw Clinical Endpoints in primary Sjögrens Syndrome: an Interventional Trial based on stratifYing patients

July 19, 2022by pcdata

Dates: 01/01/2019 31/12/2024 Topic: Biomarkers identification Project type: Clinic Preclinic Project target: Autoimmune disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE Keywords: Countries: France; UK; Sweden; Netherlands; Spain; Greece; Ireland; Norway;...

France Greece Netherlands Spain Switzerland USAHost-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

July 19, 2022by pcdata

Dates: 01/01/2020 31/12/2024 Topic: Biomarkers identification Strategies Project type: Preclinic Clinic Project target: Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.3. – Treating and managing disease Participating agents: CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES Keywords: hospital-acquired pneumonia; pneumonology; antibiotic; infectious disease; drug resistance; biomarker; strategy; OMICs; clinical trial; procedure Countries:...

Austria France Germany Greece Israel Netherlands Romania Switzerland United KingdomImmunoSep: Advancing Personalised Immunotherapy in Sepsis

July 19, 2022by pcdata

Dates: 01/01/2020 31/12/2023 Topic: Biomarkers identification Project type: Immunotherapy Project target: Autoimmune disease Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.3. – Treating and managing disease Participating agents: Radboud University Medical Center -ELLINIKO INSTITUTO MELETIS TIS SIPSIS -CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS -UNIVERSITATSKLINIKUM JENA -ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT...